Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN ONCOLOGY

Picture
David Amici, a student in the Medical Scientist Training Program, prepares a solution in the lab. Amici was lead author of the study published in Nature Communications.

February 2023

ONCOLOGY

NEW GENE IMPLICATED IN CANCER, CELLULAR STRESS RESPONSE

Featuring: ​Marc Mendillo, PhD

Northwestern Medicine scientists have identified a gene that plays a role in cellular responses to molecular stressors, such as DNA damage and nutrient scarcity, according to findings published in Nature Communications.

Marc Mendillo, PhD, assistant professor of Biochemistry and Molecular Genetics and senior author of the study, built upon his previous work identifying and characterizing HAPSTR1, which was found to be expressed in multiple types of cancer cells.

The new gene, HAPSTR2, is expressed in the brain, testis, and in certain cancers, according to the study.

​All human cells contain signaling pathways that enable them to counteract different types of cellular and environmental stressors. However, because these stress response pathways are almost always studied individually, the mechanisms which help regulate and link different stress response pathways have remained poorly understood.

In a previous study, Mendillo and his collaborators found HAPSTR1 both interacts with and is degraded by a protein called HUWE1, which has been previously implicated in different cancers and neurodevelopmental disorders. The protein is an E3 ubiquitin ligase, meaning its function is to hunt down specific other proteins and degrade them.

The previous study revealed that HUWE1 and HAPSTR1 have an unexpected relationship: HUWE1 assists HAPSTR1 in controlling stress signaling and in turn, HUWE1 feeds back to promote the degradation of HAPSTR1.

​In the latest study, investigators found HAPSTR2 to be a paralog, or duplicate, of HAPSTR1.

In normal physiology, HAPSTR2 interacts with HAPSTR1 to augment protein stability independently from  HUWE1. When HAPSTR1 is inhibited, HAPSTR2 takes over to buffer stress responses in cells.

The findings may help improve the understanding of how cancer and other diseases hijack stress response programming to survive, Mendillo said.

​“Stress response pathways play an important protective role, but cancers co-opt these pathways to allow the cancer to survive and proliferate,” said Mendillo, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “Additionally, the HAPSTR family is present in all humans. You don’t have people walking around that have obvious loss of function mutations in this gene, which leads us to believe that these genes are very important for life.”

Future research will focus on understanding the mechanisms underlying HAPSTR protein function and identifying potential treatment targets for cancer.

“This HAPSTR1 protein seems to be essential for life and for cancers to develop,” said David Amici, a student in the Medical Scientist Training Program and lead author of the study. “Our discovery of HAPSTR2 reveals an additional mechanism for cancer cells to ramp up this pathway. This is going to be important for therapy resistance and metastasis, things we ideally would like to turn off in cancer.”

This work was supported by NIH grants F30CA264513, T32GM008152 and 1R01GM144617-01, American Cancer Society grant IRG-18-163-24 and ABOA Impact grant RSG-22-086-01-TBE.


This article was originally published in the Feinberg School of Medicine News Center on February 20, 2023. ​
Marc Mendillo, PhD headshot
Marc Mendillo, PhD, assistant professor of Biochemistry and Molecular Genetics, was senior author of the study published in Nature Communications.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM oncologist

You May Also Like

Bin Zhang, MD, PHD Headshot

December 2022

ONCOLOGY
Bin Zhang, MD, PHD, Named Co-leader Of Tumor Environment And Metastasis Program
Mazhar Adli, PhD headshot

September 2022

ONCOLOGY
NIH Initiative To Systematically Investigate And Establish Function Of Every Human Gene
Huiping Liu, MD, PhD,  headshot

October 2022

ONCOLOGY
Newly Identified Protein Drives Breast Cancer Stemness And Metastasis

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties